Biblio

Export 74 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
A. N'Songo, Carrasquillo, M. M., Wang, X., Nguyen, T., Asmann, Y., Younkin, S. G., Allen, M., Duara, R., Custo, M. T. Greig, Graff-Radford, N., and Ertekin-Taner, N., “Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1215-1222, 2017.
S. Nabirotchkin, Bouaziz, J., Glibert, F., Mandel, J., Foucquier, J., Hajj, R., Callizot, N., Cholet, N., Guedj, M., and Cohen, D., “Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1585-1603, 2022.
B. Nacmias, Bagnoli, S., Piaceri, I., and Sorbi, S., “Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.”, J Alzheimers Dis, vol. 62, no. 3, pp. 903-911, 2018.
F. Nafar, J Williams, B., and Mearow, K. M., “Astrocytes release HspB1 in response to amyloid-β exposure in vitro.”, J Alzheimers Dis, vol. 49, no. 1, pp. 251-63, 2016.
M. Nagai, Dote, K., Kato, M., Sasaki, S., Oda, N., Kagawa, E., Nakano, Y., Yamane, A., Higashihara, T., Miyauchi, S., and Tsuchiya, A., “Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.”, J Alzheimers Dis, vol. 59, no. 2, pp. 515-526, 2017.
N. Nagaraja, Wang, W. - E., Duara, R., DeKosky, S. T., and Vaillancourt, D., “Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 2, pp. 495-507, 2023.
T. Nagata, Nakajima, S., Shinagawa, S., Plitman, E., Nakayama, K., Graff-Guerrero, A., and Mimura, M., “Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 60, no. 1, pp. 263-272, 2017.
T. Nagata, Shinagawa, S., Nakajima, S., Mimura, M., and Shigeta, M., “Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 139-148, 2018.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., “Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
K. Nakaizumi, Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., and Magata, Y., “In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
M. Nakajima, Miyajima, M., Ogino, I., Akiba, C., Kawamura, K., Kamohara, C., Fusegi, K., Harada, Y., Hara, T., Sugano, H., Tange, Y., Karagiozov, K., Kasuga, K., Ikeuchi, T., Tokuda, T., and Arai, H., “Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 66, no. 1, pp. 319-331, 2018.
S. Nakamura, Yomota, S., Ito, H., Akinaga, N., Hori, A., Chinomi, K., Suzuki, H., Uchida, K., and Asada, T., “A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.
N. Nakamura, Ohyagi, Y., Imamura, T., Yanagihara, Y. T., Iinuma, K. M., Soejima, N., Murai, H., Yamasaki, R., and Kira, J. - I., “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
T. Nakamura, Kawarabayashi, T., Ueda, T., Shimomura, S., Hoshino, M., Itoh, K., Ihara, K., Nakaji, S., Takatama, M., Ikeda, Y., and Shoji, M., “Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ 40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 1, pp. 333-348, 2023.
M. Nakanishi, Niimura, J., Yamasaki, S., and Nishida, A., “Death of Dementia Patients in Psychiatric Hospitals and Regional Supply of Psychiatric Services: Study of the National Data from 1996 to 2014 in Japan.”, J Alzheimers Dis, vol. 56, no. 2, pp. 817-824, 2017.
M. Nakanishi, Hirooka, K., Imai, Y., Inoue, S., Yukari, Y., Katayama, C., Miyamoto, Y., Shindo, Y., Ueno, H., Toya, J., Takano, Y., and Nishida, A., “Dementia Care Competence Among Care Professionals and Reduced Challenging Behavior of Home-Dwelling Persons with Dementia: A Pre- and Post-Intervention Data Analysis.”, J Alzheimers Dis, vol. 64, no. 2, pp. 515-523, 2018.
M. Nakanishi, Igarashi, A., Ueda, K., Brnabic, A. J. M., Treuer, T., Sato, M., Kahle-Wrobleski, K., Meguro, K., Yamada, M., Mimura, M., and Arai, H., “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
M. Nakanishi, Nakashima, T., Shindo, Y., Niimura, J., and Nishida, A., “Japanese Care Location and Medical Procedures for People with Dementia in the Last Month of Life.”, J Alzheimers Dis, vol. 51, no. 3, pp. 747-55, 2016.
S. Nakayama, Suda, A., Nakanishi, A., Motoi, Y., and Hattori, N., “Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 267-273, 2017.
B. T. Nallapu, Petersen, K. K., Lipton, R. B., Grober, E., Sperling, R. A., and Ezzati, A., “Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1381-1393, 2023.
C. Nance, Ritter, A., Miller, J. B., Lapin, B., and Banks, S. J., “The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 4, pp. 983-993, 2019.
P. L. Nara, Sindelar, D., Penn, M. S., Potempa, J., and W Griffin, S. T., “Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
P. Nardiello, Pantano, D., Lapucci, A., Stefani, M., and Casamenti, F., “Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1161-1172, 2018.
P. Naren, Cholkar, A., Kamble, S., Khan, S. Samim, Srivastava, S., Madan, J., Mehra, N., Tiwari, V., Singh, S. Bala, and Khatri, D. Kumar, “Pathological and Therapeutic Advances in Parkinson's Disease: Mitochondria in the Interplay.”, J Alzheimers Dis, vol. 94, no. s1, pp. S399-S428, 2023.
A. Naro, Corallo, F., De Salvo, S., Marra, A., Di Lorenzo, G., Muscarà, N., Russo, M., Marino, S., De Luca, R., Bramanti, P., and Calabrò, R. Salvatore, “Promising Role of Neuromodulation in Predicting the Progression of Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1375-88, 2016.

Pages